Lantheus Holdings, Inc. (LNTH) income statement
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$102.00+0.20 (+0.20%)
Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –
Lantheus Holdings, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 60.1%
- Operating margin
- 19.4%
- Net margin
- 17.7%
- Return on equity, FY2025
- 21.4%
Financial strength
- Current ratio
- 3.06
- Debt to equity
- 0.44
- Debt to assets
- 23.6%
- Cash to current liabilities
- 176.7%
Valuation
- P/E ratio
- 24.7
- Price to sales
- 4.28
- Price to book
- 5.08
- Dividend yield
- –
See a number that looks wrong?